To conduct phase i, II, III and IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N94020D00010
- Awardee
-
Albert Einstein College Of Medicine UEI H6N1ZF5HJ2G3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $266,509 obligated
Award facts
- Opportunity
-
- RFPNIHNICHDCDP20201 Solicitation number
- Combined order value
- $266,509 Current and potential, with all options
- Last date to order 89% complete
- IDV ceiling 5% used
- $5,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 19 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Child Health and Human Development awarded a multiple-award indefinite delivery contract to Albert Einstein College of Medicine with a $5 million ceiling on August 1, 2020, to conduct Phase I, II, III, and IV contraceptive clinical trials in women, treatment trials of gynecologic conditions including endometriosis and leiomyomata, and development of research protocols on a task-order basis.
The contract carries a seven-year period of performance through July 31, 2027. Place of performance is Bronx, New York.
Task orders issued under this IDIQ include a $176,019 delivery order (awarded September 28, 2023, ultimate completion April 30, 2025) supporting protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the Ovaprene vaginal device Phase I clinical trial, and a $90,490.32 delivery order (awarded August 1, 2020) to assist in the development of new contraceptive products by providing services related to protocol review, protocol development, and activities associated with past, present, and future Contraceptive Clinical Trials Network operations. Both task orders are cost-reimbursement arrangements with no fee and are being performed in Bronx, New York. The Ovaprene delivery order includes severable service provisions.
Description
To conduct phase i, II, III and IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis under a seven (7) year indefinite-delivery
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N94020D00010?
75N94020D00010 was awarded to Albert Einstein College Of Medicine by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.
How much is contract 75N94020D00010 worth?
Orders under 75N94020D00010 have obligated $266,509. 75N94020D00010's own ceiling is $5,000,000.
How many orders have been placed under contract 75N94020D00010?
2 orders have been placed under 75N94020D00010, the latest on September 28, 2023.
Who can order from contract 75N94020D00010?
75N94020D00010 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N94020D00010 competed?
The extent of competition for 75N94020D00010 was full and open competition. The government received 19 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV